Peer Review
Cancer Imaging
ISSN 1470-7330
Search site with:PicoSearch


Content
Current Issue
Archive
Related Journals / Articles
Information
Aims and Scope
Editors and Board
Editorial Policy
Instructions for Authors
Copyright Transfer Form
Subscription Information
Advertising
Society
Aims
Membership
Annual Meeting
Communications
Bulletin Board
Send Email to ICIS
e-Med
Visit e-Med Web Site
Journals
Purchase
“To Promote Education in Cancer Imaging in the Multidisciplinary Management of Malignancy”

Home > Articles

CT Demonstration of the Spontaneous Regression of a Hypervascular Lesion in Cirrhotic Liver Open Access Article

Abstract

In patients with liver cirrhosis, arterial phase enhancement of nodular lesions on helical-CT is currently considered to be highly predictive of malignancy. We report the spontaneous regression of a hypervascular hepatic nodule in a patient with liver cirrhosis within 7 months demonstrated by helical-CT follow-up. This suggests that tumour angiogenesis known to be an obligatory step for acquisition of mailignant properties could regress, and can be demonstrated by helical CT. Radiologists should be aware that CT detection of a hypervascular nodule in a cirrhotic liver is not always predictive of a malignant outcome.

Author

Alain Luciani, Alain Rahmouni, Hamid Achab, Didier Mathieu, Nedal Jazaerli, and Mohamed Bouanane

Contact Details

Corresponding address:
Docteur Alain Rahmouni
Service de Radiologie
Hopital Henri Mondor 51
Avenue du Marechal de Lattre de Tassigny
94010 Creteil
France

Reference

ICIS Cancer Imaging Volume 1 issue 2
DOI: 10.1102/1470-7330.2001.001

Date Posted

1 February 2001


Open Access Article Open Access is provided for this article.

Print PDF

Size

49.05 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):

1 second

ADSL 512Kb/s (Broadband):

1 second

64 Kb/s (ISDN):

6 seconds

33.3 Kb/s (Typical Modem):

11 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 61053, London, SE16 7YZ. Tel: +44 (0)207 719 8989 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.

© 2000-2009 International Cancer Imaging Society